Skip to content

Clinical trials

Observational Pulmonary Disease, Chronic Obstructive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Observational Country / region: United Kingdom Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20031
20041
20057
20061
20071
20082
20093
20104
201112
20126
20133
20147
20157
201612
20179
20188
201911
20208
20213
20227
202310
20247
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Unknown status28
Recruiting16
Withdrawn9
Not yet recruiting3
Active, not recruiting3
Terminated2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London22
AstraZeneca8
Guy's and St Thomas' NHS Foundation Trust7
Royal Brompton & Harefield NHS Foundation Trust7
University of Leicester7
Portsmouth Hospitals NHS Trust5
University College, London5
GlaxoSmithKline4
Research in Real-Life Ltd4
Boehringer Ingelheim3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive145
Asthma32
Emphysema10
Bronchitis, Chronic9
Heart Failure8
Lung Diseases, Interstitial8
Bronchiectasis7
Lung Neoplasms7
Dyspnea6
Lung Diseases6

Trials

Showing 1 to 25 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.